Prognostic Value of BNP in MCS - a 25 Year Follow up Study
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorRigshospitalet, Denmark
About this trial
A biobank has been created to investigate the prognostic value of biomarkers (mainly BNP) in patients implanted with durable mechanical assist devices comparing patients with advanced HF supported by MCS with those who are transplanted and those who remain on optimal medical therapy.
Patients will be followed up for 25 years after inclusion.
Eligibility criteria
Qualifiers
All patients referred for evaluation for advanced HF treatment at the Rigshospital in Denmark
Age>18 years
Disqualifiers
No consent
Trial design
Treatments tested in this trial
- Observation. No intervention per se.
- 2) Observation and collection and of blood sample
Treatment groups
1,000 Participants
are divided into 3 treatment groupsSponsors and collaborators
Source ClinicalTrials.gov